2018
DOI: 10.2147/tcrm.s172591
|View full text |Cite
|
Sign up to set email alerts
|

Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?

Abstract: BackgroundWhen prescribing antiplatelet agents, physicians face the challenge of protecting patients from thromboembolic events without inducing bleeding damage. However, especially in the perioperative period, the use of these medications requires a carefully balanced assessment of their risks and benefits.ObjectiveTo conduct a systematic review to check whether the antiplatelet agent is to be maintained or suspended in the perioperative period of noncardiac surgeries.Search strategyA comprehensive literature… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 44 publications
1
4
0
Order By: Relevance
“…This outcome is associated with the fact that adequate local treatment was applied. Similar conclusions were reported by authors of experimental control studies [30,31].…”
Section: Discussionsupporting
confidence: 92%
“…This outcome is associated with the fact that adequate local treatment was applied. Similar conclusions were reported by authors of experimental control studies [30,31].…”
Section: Discussionsupporting
confidence: 92%
“…Most neurosurgical procedures are of the moderate or high-risk category. Unlike in other types of surgeries, antiplatelet drugs (even low-dose acetylsalicylic acid) are usually discontinued before the operation [2,9,15]. In addition, the restart time of antiplatelet therapy is usually delayed as compared with that in other surgeries.…”
Section: Introductionmentioning
confidence: 99%
“…Most neurosurgical procedures are of the moderate or high-risk category. Unlike in other types of surgeries, antiplatelet drugs (even low-dose acetylsalicylic acid) are usually discontinued before the operation [2,9,15]. In addition, the restart time of antiplatelet therapy is usually delayed as compared with that in other surgeries.…”
Section: Introductionmentioning
confidence: 99%